Newer long-acting insulin prescriptions for patients with type 2 diabetes: prevalence and practice variation in a retrospective cohort study

BACKGROUND: Little is known about prescription patterns of expensive non-recommended newer long-acting insulins (glargine 300 U/mL and degludec) for patients with type 2 diabetes mellitus (T2DM). AIM: To identify practice variation in, and practice- and patient-related characteristics associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Dankers, Marloes, Hek, Karin, Nelissen-Vrancken, Marjorie, Houweling, Sebastiaan T, Mantel-Teeuwisse, Aukje, van Dijk, Liset
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172218/
https://www.ncbi.nlm.nih.gov/pubmed/35606162
http://dx.doi.org/10.3399/BJGP.2021.0581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172218/
https://www.ncbi.nlm.nih.gov/pubmed/35606162
http://dx.doi.org/10.3399/BJGP.2021.0581

Ejemplares similares